0001493152-21-021791.txt : 20210901
0001493152-21-021791.hdr.sgml : 20210901
20210901162028
ACCESSION NUMBER: 0001493152-21-021791
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210830
FILED AS OF DATE: 20210901
DATE AS OF CHANGE: 20210901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scholtes Bret
CENTRAL INDEX KEY: 0001490606
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38861
FILM NUMBER: 211230254
MAIL ADDRESS:
STREET 1: 2105 CITY WEST BLVD.
STREET 2: SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardion Health Sciences, Inc.
CENTRAL INDEX KEY: 0001642375
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474428421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15150 AVENUE OF SCIENCE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
BUSINESS PHONE: (800) 873-5141
MAIL ADDRESS:
STREET 1: 15150 AVENUE OF SCIENCE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92128
FORMER COMPANY:
FORMER CONFORMED NAME: Guardion Health Sciences, LLC
DATE OF NAME CHANGE: 20150513
4
1
ownership.xml
X0306
4
2021-08-30
0
0001642375
Guardion Health Sciences, Inc.
GHSI
0001490606
Scholtes Bret
C/O GUARDION HEALTH SCIENCES, INC.
2925 RICHMOND AVENUE, SUITE 1200
HOUSTON
TX
77098
1
1
0
0
CEO and President
Common stock
2021-08-30
4
P
0
4500
1.2568
A
173984
D
Common stock
2021-08-31
4
P
0
5500
1.2291
A
179484
D
This sales price reflects a weighted average of multiple prices ranging from $1.245 to $1.27. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
This sales price reflects a weighted average of multiple prices ranging from $1.21 to $1.25. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
/s/ Bret Scholtes
2021-09-01